Answer
Tecartus (brexucabtagene autoleucel) is not recommended during pregnancy because cells crossing the placenta may cause foetal toxicity, including B-cell lymphocytopenia; it is also not recommended for women of childbearing potential not using contraception.
Sources for this answer
- TecartusGilead Sciences Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 16Document updated
Sources checked